William T. McKee
2020
In 2020, William T. McKee earned a total compensation of $2.1M as Chief Financial Officer at C4 Therapeutics.
Compensation breakdown
Option Awards | $1,025,271 |
---|---|
Other | $1,074,474 |
Total | $2,099,745 |
McKee received $1.1M in other compensation, accounting for 51% of the total pay in 2020.
McKee also received $1M in option awards.
Rankings
In 2020, William T. McKee's compensation ranked 5,297th out of 13,090 executives tracked by ExecPay. In other words, McKee earned more than 59.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,297 out of 13,090 | 60th |
Division Manufacturing | 2,179 out of 5,624 | 61st |
Major group Chemicals And Allied Products | 870 out of 2,257 | 62nd |
Industry group Drugs | 749 out of 1,957 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 179 out of 411 | 56th |
Source: SEC filing on April 26, 2021.
McKee's colleagues
We found five more compensation records of executives who worked with William T. McKee at C4 Therapeutics in 2020.
2020
Andrew Hirsch
C4 Therapeutics
Chief Executive Officer
2020
Marc Cohen
C4 Therapeutics
Chief Executive Officer
2020
Adam Crystal
C4 Therapeutics
Chief Medical Officer
2020
Stewart Fisher
C4 Therapeutics
Chief Scientific Officer
2020
Andrew Phillips
C4 Therapeutics